{"id":1044,"date":"2026-05-18T17:30:53","date_gmt":"2026-05-18T14:30:53","guid":{"rendered":"https:\/\/life-peptide.com\/?post_type=product&#038;p=1044"},"modified":"2026-08-05T16:14:24","modified_gmt":"2026-08-05T13:14:24","slug":"cagrilintide-5-mg","status":"publish","type":"product","link":"https:\/\/life-peptide.com\/cs\/product\/cagrilintide-5-mg\/","title":{"rendered":"Cagrilintid 5 mg"},"content":{"rendered":"<p>Cagrilintide je <strong>dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu<\/strong>, co\u017e je p\u0159irozen\u011b se vyskytuj\u00edc\u00ed peptidov\u00fd hormon, kter\u00fd slinivka b\u0159i\u0161n\u00ed (beta bu\u0148ky) vylu\u010duje spole\u010dn\u011b s inzul\u00ednem po p\u0159\u00edjmu potravy.<\/p>\n<p>Na rozd\u00edl od <a href=\"https:\/\/life-peptide.com\/cs\/product\/semaglutide-10-mg\/\">Semaglutid<\/a>, <a href=\"https:\/\/life-peptide.com\/cs\/product\/tirzepatide-10-mg\/\">Tirzepatid<\/a> a <a href=\"https:\/\/life-peptide.com\/cs\/product\/retatrutide-10-mg\/\">Retatrutid<\/a>, kter\u00e9 p\u016fsob\u00ed prim\u00e1rn\u011b prost\u0159ednictv\u00edm inkretinov\u00fdch drah, se cagrilintide zam\u011b\u0159uje <strong>syst\u00e9my receptor\u016f pro amylin a kalcitonin<\/strong>, \u010d\u00edm\u017e p\u0159edstavuje dopl\u0148kov\u00fd mechanismus pro regulaci chuti k j\u00eddlu a energetick\u00e9 rovnov\u00e1hy. Tato specifick\u00e1 farmakologie z n\u011bj \u010din\u00ed jednu z nejv\u00fdznamn\u011bj\u0161\u00edch zkouman\u00fdch slou\u010denin v modern\u00edm v\u00fdzkumu metabolick\u00fdch peptid\u016f.<\/p>\n<p>Jeliko\u017e se jeho mechanismus z\u00e1sadn\u011b li\u0161\u00ed od agonist\u016f GLP-1 receptor\u016f, stal se kagrilintid d\u016fle\u017eitou molekulou pro v\u00fdzkumn\u00edky zab\u00fdvaj\u00edc\u00ed se kombinovan\u00fdmi terapiemi, kter\u00e9 aktivuj\u00ed v\u00edce dr\u00e1h reguluj\u00edc\u00edch chu\u0165 k j\u00eddlu sou\u010dasn\u011b.<\/p>\n<p><em>Chcete si v Evrop\u011b koupit cagrilintid? Spole\u010dnost Life Peptide dod\u00e1v\u00e1 cagrilintid vysok\u00e9 \u010distoty pro laboratorn\u00ed v\u00fdzkum a zaji\u0161\u0165uje spolehlivou dopravu po cel\u00e9 EU.<\/em><\/p>\n<hr \/>\n<h4><strong>Pro\u010d je cagrilintid d\u016fle\u017eit\u00fd pro v\u00fdzkum metabolismu<\/strong><\/h4>\n<p>Cagrilintide p\u0159edstavuje jeden z prvn\u00edch dlouhodob\u011b p\u016fsob\u00edc\u00edch analog\u016f amylinu schopn\u00fdch udr\u017eet trvalou aktivaci receptor\u016f p\u0159i pod\u00e1v\u00e1n\u00ed jednou t\u00fddn\u011b v publikovan\u00e9m klinick\u00e9m v\u00fdzkumu.<\/p>\n<p>D\u00edky sv\u00e9mu jedine\u010dn\u00e9mu mechanismu se stal d\u016fle\u017eit\u00fdm v\u00fdzkumn\u00fdm n\u00e1strojem pro studium:<\/p>\n<ul>\n<li><strong>regulace chuti k j\u00eddlu<\/strong><\/li>\n<li><strong>signalizace sytosti<\/strong><\/li>\n<li><strong>vypr\u00e1zd\u0148ov\u00e1n\u00ed \u017ealudku<\/strong><\/li>\n<li><strong>energetick\u00e1 bilance<\/strong><\/li>\n<li><strong>regulace t\u011blesn\u00e9 hmotnosti<\/strong><\/li>\n<li><strong>biologie amylinu<\/strong><\/li>\n<li><strong>kombinovan\u00e1 l\u00e9\u010dba agonisty receptoru GLP-1<\/strong><\/li>\n<\/ul>\n<p>Cagrilintid nen\u00ed zkoum\u00e1n jako n\u00e1hrada agonist\u016f GLP-1, ale sp\u00ed\u0161e jako <strong>komplement\u00e1rn\u00ed metabolick\u00fd peptid<\/strong> proto\u017ee aktivuje fyziologick\u00e9 sign\u00e1ln\u00ed dr\u00e1hy, kter\u00e9 se li\u0161\u00ed od samotn\u00e9 inkretinov\u00e9 signalizace.<\/p>\n<hr \/>\n<h4><strong>Jak p\u016fsob\u00ed cagrilintid<\/strong><\/h4>\n<p>Cagrilintide prim\u00e1rn\u011b <strong>aktivuje amylinov\u00e9 receptory<\/strong>, p\u0159i\u010dem\u017e k tomu doch\u00e1z\u00ed i prost\u0159ednictv\u00edm komplex\u016f kalcitoninov\u00fdch receptor\u016f.<\/p>\n<p>Amylin se po j\u00eddle p\u0159irozen\u011b uvol\u0148uje spole\u010dn\u011b s inzul\u00ednem a pod\u00edl\u00ed se na fyziologick\u00e9 regulaci:<\/p>\n<ul>\n<li><strong>pocit sytosti<\/strong><\/li>\n<li><strong>vypr\u00e1zd\u0148ov\u00e1n\u00ed \u017ealudku<\/strong><\/li>\n<li><strong>vylu\u010dov\u00e1n\u00ed glukagonu<\/strong><\/li>\n<li><strong>p\u0159\u00edjem potravy<\/strong><\/li>\n<\/ul>\n<p>Na rozd\u00edl od agonist\u016f receptoru GLP-1, kter\u00e9 p\u0159edev\u0161\u00edm zesiluj\u00ed inkretinovou signalizaci, cagrilintid napodobuje kl\u00ed\u010dov\u00e9 aspekty fyziologie endogenn\u00edho amylinu. Tento dopl\u0148kov\u00fd mechanismus vysv\u011btluje, pro\u010d se stal <strong>hlavn\u00ed zam\u011b\u0159en\u00ed v\u00fdzkumu kombinac\u00ed<\/strong> se semaglutidem a dal\u0161\u00edmi peptidy na b\u00e1zi inkretin\u016f.<\/p>\n<hr \/>\n<h4><strong>Zve\u0159ejn\u011bn\u00e9 klinick\u00e9 v\u00fdsledky t\u00fdkaj\u00edc\u00ed se cagrilintidu<\/strong><\/h4>\n<p>Klinick\u00e9 studie na lidech prok\u00e1zaly, \u017ee zkouman\u00fd p\u0159\u00edpravek Cagrilintide vyvol\u00e1v\u00e1 <strong>d\u00e1vkov\u011b z\u00e1visl\u00e9 sn\u00ed\u017een\u00ed t\u011blesn\u00e9 hmotnosti<\/strong> spolu se zlep\u0161en\u00edmi v oblasti <strong>regulace chuti k j\u00eddlu a pocit sytosti<\/strong>. Ve studii f\u00e1ze II zam\u011b\u0159en\u00e9 na stanoven\u00ed d\u00e1vky, jej\u00ed\u017e v\u00fdsledky byly publikov\u00e1ny v \u010dasopise The Lancet, vedlo pod\u00e1v\u00e1n\u00ed p\u0159\u00edpravku Cagrilintide jednou t\u00fddn\u011b k v\u00fdznamn\u011b v\u011bt\u0161\u00edmu sn\u00ed\u017een\u00ed t\u011blesn\u00e9 hmotnosti ne\u017e placebo a bylo obecn\u011b dob\u0159e sn\u00e1\u0161eno v cel\u00e9m zkouman\u00e9m rozmez\u00ed d\u00e1vek.<\/p>\n<p>Jedn\u00edm z nejv\u00fdznamn\u011bj\u0161\u00edch pokrok\u016f v n\u00e1sledn\u00e9m v\u00fdzkumu bylo zkoum\u00e1n\u00ed cagrilintidu v kombinaci se semaglutidem. Tyto dv\u011b molekuly nep\u016fsob\u00ed na stejn\u00fd receptor, ale <strong>zapojit dopl\u0148kov\u00e9 biologick\u00e9 dr\u00e1hy<\/strong>, co\u017e umo\u017e\u0148uje v\u011bdc\u016fm posoudit, zda kombinovan\u00e1 signalizace amylinu a GLP-1 vede k <strong>\u0161ir\u0161\u00ed metabolick\u00e9 \u00fa\u010dinky ne\u017e kter\u00fdkoli z t\u011bchto mechanism\u016f samostatn\u011b<\/strong>. N\u00e1sledn\u00e9 studie kombinovan\u00e9 l\u00e9\u010dby tento p\u0159\u00edstup potvrdily a p\u0159isp\u011bly k tomu, \u017ee se Cagrilintid stal kl\u00ed\u010dov\u00fdm partnerem ve v\u00fdzkumu metabolismu zalo\u017een\u00e9m na GLP-1.<\/p>\n<hr \/>\n<h4><strong>Publikovan\u00e9 v\u00fdsledky t\u00fdkaj\u00edc\u00ed se bezpe\u010dnosti a sn\u00e1\u0161enlivosti<\/strong><\/h4>\n<p>Zve\u0159ejn\u011bn\u00e9 klinick\u00e9 studie nazna\u010duj\u00ed, \u017ee nej\u010dast\u011bji hl\u00e1\u0161en\u00fdmi ne\u017e\u00e1douc\u00edmi \u00fa\u010dinky u zkouman\u00e9ho p\u0159\u00edpravku Cagrilintide jsou gastrointestin\u00e1ln\u00ed p\u0159\u00edznaky, v\u010detn\u011b <strong>nevolnost, zvracen\u00ed a za\u017e\u00edvac\u00ed pot\u00ed\u017ee<\/strong>. Podobn\u011b jako u agonist\u016f receptoru GLP-1 byly tyto p\u0159\u00edhody obecn\u011b <strong>d\u00e1vkov\u011b z\u00e1visl\u00fd<\/strong> a vyskytovaly se nej\u010dast\u011bji b\u011bhem zvy\u0161ov\u00e1n\u00ed d\u00e1vky. V\u011bt\u0161ina z nich byla hl\u00e1\u0161ena jako m\u00edrn\u00e1 a\u017e st\u0159edn\u011b z\u00e1va\u017en\u00e1.<\/p>\n<p>Vzhledem k tomu, \u017ee se cagrilintid b\u011b\u017en\u011b zkoum\u00e1 spole\u010dn\u011b s agonisty receptoru GLP-1, z\u016fst\u00e1v\u00e1 sn\u00e1\u0161enlivost d\u016fle\u017eitou sou\u010d\u00e1st\u00ed prob\u00edhaj\u00edc\u00edho klinick\u00e9ho v\u00fdzkumu. Publikovan\u00e9 studie proto hodnot\u00ed nejen \u00fa\u010dinnost, ale tak\u00e9 rovnov\u00e1hu mezi v\u00fdsledky souvisej\u00edc\u00edmi s chut\u00ed k j\u00eddlu a gastrointestin\u00e1ln\u00ed sn\u00e1\u0161enlivost\u00ed.<\/p>\n<hr \/>\n<h4><strong>Publikovan\u00e1 d\u00e1vkov\u00e1 sch\u00e9mata pou\u017eit\u00e1 ve v\u00fdzkumu cagrilintidu<\/strong><\/h4>\n<p>Publikovan\u00e9 klinick\u00e9 studie obecn\u011b zkoumaly <strong>pod\u00e1v\u00e1n\u00ed jednou t\u00fddn\u011b s postupnou eskalac\u00ed d\u00e1vky<\/strong> sp\u00ed\u0161e ne\u017e okam\u017eit\u00e9 zah\u00e1jen\u00ed l\u00e9\u010dby vy\u0161\u0161\u00edmi udr\u017eovac\u00edmi d\u00e1vkami. Ve 2. f\u00e1zi studi\u00ed obezity bylo hodnoceno n\u011bkolik \u00farovn\u00ed d\u00e1vkov\u00e1n\u00ed s c\u00edlem charakterizovat \u00fa\u010dinnost i sn\u00e1\u0161enlivost v cel\u00e9m rozmez\u00ed d\u00e1vek.<\/p>\n<p>Nov\u011bj\u0161\u00ed kombina\u010dn\u00ed studie hodnot\u00edc\u00ed cagrilintid spolu se semaglutidem nad\u00e1le vyu\u017e\u00edvaj\u00ed strukturovan\u00e9 pl\u00e1ny titrace podobn\u00e9 t\u011bm, kter\u00e9 se pou\u017e\u00edvaj\u00ed v cel\u00e9 \u0161ir\u0161\u00ed oblasti inkretin\u016f. Tyto publikovan\u00e9 pl\u00e1ny jsou prezentov\u00e1ny jako shrnut\u00ed designu klinick\u00fdch hodnocen\u00ed a nem\u011bly by b\u00fdt vykl\u00e1d\u00e1ny jako n\u00e1vod k pou\u017eit\u00ed.<\/p>\n<hr \/>\n<h4><strong>Cagrilintid vs Semaglutid vs Tirzepatid<\/strong><\/h4>\n<p><strong>Kagrilintid<\/strong><\/p>\n<ul>\n<li><strong>Dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu<\/strong><\/li>\n<li>Aktivita receptor\u016f pro amylin a kalcitonin<\/li>\n<li>Dopl\u0148uj\u00edc\u00ed inkretinovou signalizaci<\/li>\n<li>\u010casto zkoum\u00e1no v kombinaci s agonisty GLP-1<\/li>\n<\/ul>\n<p><a href=\"https:\/\/life-peptide.com\/cs\/product\/semaglutide-10-mg\/\"><strong>Semaglutid<\/strong><\/a><\/p>\n<ul>\n<li><strong>Agonista receptoru GLP-1<\/strong><\/li>\n<li>Z\u00e1klad v\u00fdzkumu GLP-1<\/li>\n<li>Rozs\u00e1hl\u00e9 klinick\u00e9 d\u016fkazy<\/li>\n<\/ul>\n<p><a href=\"https:\/\/life-peptide.com\/cs\/product\/tirzepatide-10-mg\/\"><strong>Tirzepatid<\/strong><\/a><\/p>\n<ul>\n<li><strong>Du\u00e1ln\u00ed agonista GLP-1 \/ GIP<\/strong><\/li>\n<li>Zv\u00fd\u0161en\u00e1 inkretinov\u00e1 signalizace<\/li>\n<li>\u010casto srovn\u00e1v\u00e1no s kombina\u010dn\u00edmi strategiemi zahrnuj\u00edc\u00edmi kagrilintid<\/li>\n<\/ul>\n<hr \/>\n<h4><strong>Vlastnosti produktu<\/strong><\/h4>\n<p>Aplikace: laboratorn\u00ed a analytick\u00fd v\u00fdzkum<br \/>\nPou\u017eit\u00ed omezen\u00e9: nen\u00ed ur\u010deno k lidsk\u00e9 spot\u0159eb\u011b; pro l\u00e9ka\u0159sk\u00e9, veterin\u00e1rn\u00ed ani kosmetick\u00e9 pou\u017eit\u00ed<br \/>\nVyrobeno v za\u0159\u00edzen\u00edch spl\u0148uj\u00edc\u00edch spr\u00e1vnou v\u00fdrobn\u00ed praxi (GMP) za p\u0159\u00edsn\u00fdch protokol\u016f kontroly kvality.<br \/>\nKa\u017ed\u00e1 \u0161ar\u017ee je po v\u00fdrob\u011b pe\u010dliv\u011b laboratorn\u011b testov\u00e1na (Certifik\u00e1t o anal\u00fdze najdete pod obr\u00e1zky produkt\u016f).<br \/>\nLyofilizov\u00e1no (su\u0161eno mrazem) pro maxim\u00e1ln\u00ed stabilitu a prodlou\u017eenou trvanlivost.<br \/>\nUzav\u0159eno ve steriln\u00edch lahvi\u010dk\u00e1ch, p\u0159ipraveno k rekonstituci.<br \/>\n\u010cistota: \u2265 98,61 TP4T (HPLC)<br \/>\nVzhled: b\u00edl\u00fd lyofilizovan\u00fd pr\u00e1\u0161ek<br \/>\nMolekul\u00e1rn\u00ed vzorec: C<sub>194<\/sub>H<sub>312<\/sub>N<sub>54<\/sub>O<sub>59<\/sub> S<sub>2<\/sub><br \/>\nMolekulov\u00e1 hmotnost: 4409,01<br \/>\nSekvence: {diacid-C20-\u03b3-Glu}KCNTATCATQRLAEFLRHSSNNFGPILPPTNVGSNTP-NH2<\/p>\n<p><strong>\u00dalo\u017ei\u0161t\u011b<\/strong>Neotev\u0159en\u00e9 lyofilizovan\u00e9 lahvi\u010dky jsou nejl\u00e9pe skladov\u00e1ny <strong>chlazen\u00e9 p\u0159i 2\u20138 \u00b0C<\/strong>, co\u017e je metoda skladov\u00e1n\u00ed potvrzen\u00e1 na\u0161\u00edm v\u00fdrobn\u00edm partnerem a vhodn\u00e1 a\u017e po dobu 24 m\u011bs\u00edc\u016f. Preferuje se chlazen\u00ed, proto\u017ee minimalizuje zbyte\u010dn\u00e9 cykly zmrazov\u00e1n\u00ed a rozmrazov\u00e1n\u00ed b\u011bhem b\u011b\u017en\u00e9 manipulace. Pokud je vy\u017eadov\u00e1no podstatn\u011b del\u0161\u00ed skladov\u00e1n\u00ed, lze zmrazen\u00e9 uchov\u00e1vat i neotev\u0159en\u00e9 lyofilizovan\u00e9 lahvi\u010dky. Po rekonstituci v\u017edy skladujte p\u0159i 2\u20138 \u00b0C a nezmrazujte.<\/p>\n<hr \/>\n<h4><strong>Rekonstituce a manipulace<\/strong><\/h4>\n<p>Cagrilintide je dod\u00e1v\u00e1n jako lyofilizovan\u00e1 injek\u010dn\u00ed lahvi\u010dka a s p\u0159\u00edpravkem by m\u011blo b\u00fdt zach\u00e1zeno za pou\u017eit\u00ed standardn\u00edch postup\u016f rekonstituce peptid\u016f vhodn\u00fdch pro v\u00fdzkumn\u00e9 prost\u0159ed\u00ed. Mus\u00ed b\u00fdt rekonstituov\u00e1n pomoc\u00ed <a href=\"https:\/\/life-peptide.com\/cs\/product\/bac-10-ml\/\">bakteriostatick\u00e1 voda<\/a> p\u0159ed pou\u017eit\u00edm. Peptidy t\u0159\u00eddy GLP-1 se n\u011bkdy rozpou\u0161t\u011bj\u00ed pomalu a vy\u017eaduj\u00ed velmi jemn\u00e9 rozpou\u0161t\u011bn\u00ed, aby se zabr\u00e1nilo p\u011bn\u011bn\u00ed nebo vzniku m\u00edrn\u00e9ho z\u00e1kalu.<\/p>\n<p>Pro dal\u0161\u00ed pokyny k v\u00fdb\u011bru rozpou\u0161t\u011bdla, pl\u00e1nov\u00e1n\u00ed koncentrac\u00ed a skladov\u00e1n\u00ed viz \u00fapln\u00e9 <a href=\"https:\/\/life-peptide.com\/cs\/reconstitution-of-peptides\/\">Pr\u016fvodce rekonstituc\u00ed peptid\u016f<\/a> a <a href=\"https:\/\/life-peptide.com\/cs\/calculator\/\">Kalkula\u010dka rekonstituce<\/a>.<\/p>\n<hr \/>\n<h4>Kl\u00ed\u010dov\u00e9 publikovan\u00e9 studie<\/h4>\n<ul>\n<li>Lau DCW a kol.\u00a0<em>T\u00fddenn\u00ed pod\u00e1v\u00e1n\u00ed Cagrilintidu pro zvl\u00e1d\u00e1n\u00ed hmotnosti u osob s nadv\u00e1hou nebo obezitou. The Lancet<\/em>. 2021.<\/li>\n<\/ul>\n<p>Pelom\u00edstn\u00e1 studie f\u00e1ze 2 zam\u011b\u0159en\u00e1 na hled\u00e1n\u00ed d\u00e1vky, kter\u00e1 prok\u00e1zala v\u00fdznamn\u00e9 sn\u00ed\u017een\u00ed t\u011blesn\u00e9 hmotnosti z\u00e1visl\u00e9 na d\u00e1vce a stanovila cagrilintid jako p\u0159edn\u00ed dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu pro metabolick\u00fd v\u00fdzkum.<\/p>\n<ul>\n<li>Kruse T. a kol.\u00a0<em>V\u00fdvoj cagrilintidu, dlouhodob\u011b p\u016fsob\u00edc\u00edho analogu amylinu. Journal of Medicinal Chemistry.<\/em> 2021.<\/li>\n<\/ul>\n<p>Z\u00e1kladn\u00ed publikace z oblasti medic\u00ednsk\u00e9 chemie, kter\u00e1 popisuje molekul\u00e1rn\u00ed n\u00e1vrh, farmakologii receptor\u016f a strategii v\u00fdvoje p\u0159\u00edpravku Cagrilintide jako dlouhodob\u011b p\u016fsob\u00edc\u00edho analogu amylinu.<\/p>\n<ul>\n<li>Frias JP a kol.\u00a0<em>\u00da\u010dinnost a bezpe\u010dnost soub\u011b\u017en\u00e9ho pod\u00e1v\u00e1n\u00ed cagrilintidu a semaglutidu u pacient\u016f s diabetem 2. typu. The Lancet.<\/em> 2023.<\/li>\n<\/ul>\n<p>Kl\u00ed\u010dov\u00e1 klinick\u00e1 studie hodnot\u00edc\u00ed kombinovanou l\u00e9\u010dbu amylinem a agonisty receptoru GLP-1, kter\u00e1 poskytla v\u011bdeck\u00e9 podklady pro n\u00e1sledn\u00fd v\u00fdzkum p\u0159\u00edpravku CagriSema.<\/p>\n<ul>\n<li>D\u2019Ascanio AM a kol.\u00a0<em>Kagrilintid: Dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu pro l\u00e9\u010dbu obezity. Cardiology in Review.<\/em> 2023.<\/li>\n<\/ul>\n<p>Komplexn\u00ed p\u0159ehled shrnuj\u00edc\u00ed farmakologii, mechanismus \u00fa\u010dinku, klinick\u00fd v\u00fdvoj a roli cagrilintidu v modern\u00edm metabolick\u00e9m v\u00fdzkumu.<\/p>\n<hr \/>\n<h4><strong>\u010casto kladen\u00e9 ot\u00e1zky<\/strong><\/h4>\n<p><strong>Co je Cagrilintide?<\/strong><\/p>\n<p>Cagrilintid je dlouhodob\u011b p\u016fsob\u00edc\u00ed analog hormonu amylinu, jeho\u017e \u00fa\u010delem je napodobit a prodlou\u017eit fyziologickou signalizaci amylinu. Na rozd\u00edl od agonist\u016f receptoru GLP-1 p\u016fsob\u00ed p\u0159edev\u0161\u00edm na sign\u00e1ln\u00ed dr\u00e1hy receptoru amylinu, co\u017e z n\u011bj \u010din\u00ed jeden z p\u0159edn\u00edch peptid\u016f ve v\u00fdzkumu regulace chuti k j\u00eddlu a biologie pocitu sytosti.<\/p>\n<p><strong>Jak p\u016fsob\u00ed Cagrilintide?<\/strong><\/p>\n<p>Cagrilintid aktivuje syst\u00e9my amylinov\u00fdch receptor\u016f, kter\u00e9 se pod\u00edlej\u00ed na pocitu sytosti, vyprazd\u0148ov\u00e1n\u00ed \u017ealudku a energetick\u00e9 rovnov\u00e1ze. Jeho mechanismus p\u016fsoben\u00ed sp\u00ed\u0161e dopl\u0148uje ne\u017e duplikuje sign\u00e1ln\u00ed dr\u00e1hu GLP-1 receptor\u016f, a proto je \u010dasto zkoum\u00e1n spole\u010dn\u011b s agonisty GLP-1, jako je nap\u0159\u00edklad semaglutid.<\/p>\n<p><strong>Pro\u010d se Cagrilintide \u010dasto kombinuje se Semaglutidem?<\/strong><\/p>\n<p>Cagrilintid a semaglutid p\u016fsob\u00ed prost\u0159ednictv\u00edm odli\u0161n\u00fdch biologick\u00fdch drah. Cagrilintid se zam\u011b\u0159uje p\u0159edev\u0161\u00edm na signalizaci prost\u0159ednictv\u00edm amylinov\u00e9ho receptoru, zat\u00edmco semaglutid aktivuje receptor GLP-1. V publikovan\u00fdch klinick\u00fdch studi\u00edch se zkoumalo, zda kombinace t\u011bchto komplement\u00e1rn\u00edch mechanism\u016f m\u016f\u017ee vyvolat \u0161ir\u0161\u00ed metabolick\u00e9 \u00fa\u010dinky ne\u017e ka\u017ed\u00e1 z t\u011bchto drah samostatn\u011b.<\/p>\n<p><strong>V \u010dem se Cagrilintid li\u0161\u00ed od agonist\u016f receptoru GLP-1?<\/strong><\/p>\n<p>Na rozd\u00edl od semaglutidu, tirzepatidu a retatrutidu nen\u00ed cagrilintid agonistou inkretinov\u00fdch receptor\u016f. Jedn\u00e1 se o dlouhodob\u011b p\u016fsob\u00edc\u00ed analog amylinu s odli\u0161n\u00fdm mechanismem \u00fa\u010dinku, co\u017e z n\u011bj \u010din\u00ed v\u00fdznamn\u00fd p\u0159\u00ednos pro metabolick\u00fd v\u00fdzkum, a nikoli pouze dal\u0161\u00ed peptid odvozen\u00fd od GLP-1.<\/p>\n<p><strong>V jak\u00fdch oblastech v\u00fdzkumu se obvykle zkoum\u00e1 cagrilintid?<\/strong><\/p>\n<p>V dosavadn\u00edch studi\u00edch byl cagrilintid zkoum\u00e1n z hlediska regulace chuti k j\u00eddlu, signalizace sytosti, vlivu na t\u011blesnou hmotnost, vyprazd\u0148ov\u00e1n\u00ed \u017ealudku, energetick\u00e9 bilance a kombinovan\u00e9 l\u00e9\u010dby s agonisty receptoru GLP-1. D\u00edky sv\u00fdm jedine\u010dn\u00fdm farmakologick\u00fdm vlastnostem se stal jednou z p\u0159edn\u00edch molekul ve v\u00fdzkumu metabolismu zalo\u017een\u00e9m na amylinu.<\/p>\n<p><strong>M\u016f\u017eu si v Evrop\u011b koupit Cagrilintide?<\/strong><\/p>\n<p>Ano. Cagrilintide zas\u00edl\u00e1me do v\u011bt\u0161iny evropsk\u00fdch zem\u00ed pomoc\u00ed spolehliv\u00fdch kur\u00fdrn\u00edch slu\u017eeb. Dostupn\u00e9 zp\u016fsoby dopravy a dodac\u00ed lh\u016fty se zobraz\u00ed b\u011bhem dokon\u010den\u00ed objedn\u00e1vky na z\u00e1klad\u011b va\u0161\u00ed c\u00edlov\u00e9 destinace.<\/p>\n<p><strong>Je tento produkt ur\u010den k lidsk\u00e9mu pou\u017eit\u00ed?<\/strong><\/p>\n<p>Ne. Cagrilintid dod\u00e1van\u00fd spole\u010dnost\u00ed Life Peptide je ur\u010den v\u00fdhradn\u011b pro laboratorn\u00ed v\u00fdzkum a analytick\u00e9 \u00fa\u010dely. Nen\u00ed ur\u010den k lidsk\u00e9 spot\u0159eb\u011b, diagnostice, l\u00e9\u010db\u011b ani prevenci nemoc\u00ed. Jak\u00e9koli zm\u00ednky o publikovan\u00fdch klinick\u00fdch studi\u00edch na t\u00e9to str\u00e1nce jsou uvedeny v\u00fdhradn\u011b za \u00fa\u010delem shrnut\u00ed aktu\u00e1ln\u00ed v\u011bdeck\u00e9 literatury t\u00fdkaj\u00edc\u00ed se molekuly cagrilintidu.<\/p>\n<hr \/>\n<h4><strong>Souvisej\u00edc\u00ed v\u00fdzkumn\u00fd kontext<\/strong><\/h4>\n<p>Cagrilintide pat\u0159\u00ed do t\u0159\u00eddy analog\u016f amylinu v r\u00e1mci metabolick\u00e9ho v\u00fdzkumu.<br \/>\nPro srovn\u00e1vac\u00ed r\u00e1mce:<br \/>\n\u2022 Agonist\u00e9 GLP-1 receptor\u016f (nap\u0159., <a href=\"https:\/\/life-peptide.com\/cs\/product\/semaglutide-10-mg\/\">Semaglutid<\/a>)<br \/>\n\u2022 Du\u00e1ln\u00ed agonist\u00e9 (nap\u0159., <a href=\"https:\/\/life-peptide.com\/cs\/product\/tirzepatide-10-mg\/\">Tirzepatid<\/a>)<br \/>\n\u2022 Kombina\u010dn\u00ed modely (nap\u0159. v\u00fdzkumn\u00e9 r\u00e1mce CagriSema)<br \/>\nPro \u0161ir\u0161\u00ed srovn\u00e1n\u00ed mechanism\u016f viz <a href=\"\/cs\/glp-1-metabolic-research-guide\/\">Pr\u016fvodce v\u00fdzkumem metabolismu GLP-1<\/a> a prozkoumejte <a href=\"\/cs\/category\/metabolic-research-peptides\/\">Metabolick\u00fd v\u00fdzkum<\/a> pro p\u0159\u00edbuzn\u00e9 slou\u010deniny.<\/p>\n<hr \/>\n<p><strong>POZN\u00c1MKA<\/strong>Toto je pouze pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a nep\u0159edstavuje l\u00e9ka\u0159skou radu.<\/p>\n<p><strong>Z\u0159eknut\u00ed se odpov\u011bdnosti<\/strong><br \/>\nTento produkt je prod\u00e1v\u00e1n pouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely. Nen\u00ed ur\u010den k diagnostice, l\u00e9\u010db\u011b, vyl\u00e9\u010den\u00ed nebo prevenci jak\u00fdchkoli onemocn\u011bn\u00ed. Kupuj\u00edc\u00ed p\u0159eb\u00edr\u00e1 plnou odpov\u011bdnost za \u0159\u00e1dnou manipulaci a pou\u017eit\u00ed.<\/p>","protected":false},"excerpt":{"rendered":"<p>Cagrilintid 5 mg je v\u00fdzkumn\u011b \u010dist\u00fd analog amylinu s dlouhodob\u00fdm \u00fa\u010dinkem, dod\u00e1van\u00fd v lyofilizovan\u00e9 form\u011b pro laboratorn\u00ed pou\u017eit\u00ed. Stal se jedn\u00edm z p\u0159edn\u00edch zkouman\u00fdch peptid\u016f pro metabolick\u00fd v\u00fdzkum, zejm\u00e9na ve studi\u00edch regulace chuti k j\u00eddlu, sign\u00e1l\u016f sytosti a kombinovan\u00fdch p\u0159\u00edstup\u016f s agonisty receptoru GLP-1, jako je Semaglutid.<\/p>\n<p>||<\/p>\n<p>\u010cistota \u226598% | N\u00e1kup v Evrop\u011b s dopravou od 5 \u20ac | Mo\u017enost volby dopravy zdarma | P\u0159ij\u00edm\u00e1me platby kartou<\/p>","protected":false},"featured_media":1045,"template":"","meta":[],"product_brand":[],"product_cat":[19],"product_tag":[152,249,257,288,247,153,252,159,246],"class_list":["post-1044","product","type-product","status-publish","has-post-thumbnail","product_cat-metabolic-research-peptides","product_tag-amylin-analogue","product_tag-appetite-pathways","product_tag-appetite-regulation","product_tag-buy-cagrilintide","product_tag-metabolic-peptide","product_tag-metabolic-research","product_tag-obesity-research","product_tag-satiety-signaling","product_tag-weight-loss-peptide","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product\/1044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/media\/1045"}],"wp:attachment":[{"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/media?parent=1044"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_brand?post=1044"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_cat?post=1044"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/life-peptide.com\/cs\/wp-json\/wp\/v2\/product_tag?post=1044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}